U Vehling-Kaiser
Overview
Explore the profile of U Vehling-Kaiser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alig A, Modest D, Stintzing S, Heinrich K, Geissler M, Fischer von Weikersthal L, et al.
ESMO Open
. 2024 Aug;
9(9):103677.
PMID: 39173562
Background: Primary tumor (PT) sidedness is an established prognostic marker in metastatic colorectal cancer (mCRC) and has a predictive impact on the efficacy of anti-epidermal growth factor receptor (anti-EGFR) antibody...
2.
Boukovala M, Modest D, Ricard I, Fischer von Weikersthal L, Decker T, Vehling-Kaiser U, et al.
ESMO Open
. 2024 May;
9(5):103374.
PMID: 38744100
Background: The inflammation-based modified Glasgow Prognostic Score (mGPS) combines serum levels of C-reactive protein and albumin and was shown to predict survival in advanced cancer. We aimed to elucidate the...
3.
WEISS L, Karthaus M, Riera-Knorrenschild J, Kretzschmar A, Welslau M, Vehling-Kaiser U, et al.
ESMO Open
. 2022 Feb;
7(1):100391.
PMID: 35149429
Introduction: Trifluridine/tipiracil (FTD/TPI) improved both overall and progression-free survival (OS, PFS) of patients with pre-treated metastatic colorectal cancer (mCRC) in the pivotal phase III RECOURSE trial. However, health-related quality of...
4.
Holch J, Ricard I, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A, et al.
Eur J Cancer
. 2018 Nov;
106:115-125.
PMID: 30496943
Purpose: Increased baseline carcinoembryonic antigen (CEA) serum level is associated with inferior overall survival (OS) in metastatic colorectal cancer (mCRC). However, limited data exist on its predictive relevance for targeted...
5.
Modest D, Ricard I, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A, et al.
Eur J Cancer
. 2017 Aug;
84:262-269.
PMID: 28843184
Background: We explored the impacts of sequential application of various treatment lines on survival kinetics. Therefore, differences in overall survival (OS) observed in FIRE-3 were investigated in the context of...
6.
Hoechstetter M, Busch R, Eichhorst B, Buhler A, Winkler D, Eckart M, et al.
Leukemia
. 2017 Aug;
31(12):2833-2837.
PMID: 28804126
No abstract available.
7.
Kaiser F, Rudloff L, Vehling-Kaiser U, Hollburg W, Nauck F, Alt-Epping B
Ann Hematol
. 2017 Jun;
96(9):1557-1562.
PMID: 28638954
Patients with advanced haematological malignancies in non-curative settings suffer from complex physical symptoms and psychosocial distress, comparable to patients with solid tumour entities. Nevertheless, numerous problems at the interface between...
8.
Stintzing S, Miller-Phillips L, Modest D, Fischer von Weikersthal L, Decker T, Kiani A, et al.
Eur J Cancer
. 2017 May;
79:50-60.
PMID: 28463756
Background: RAS and BRAF mutations have been identified as negative prognostic factors in metastatic colorectal cancer. Efficacy of 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) plus bevacizumab in patients with RAS-mutant tumours needs...
9.
Michl M, Stintzing S, Fischer von Weikersthal L, Decker T, Kiani A, Vehling-Kaiser U, et al.
Ann Oncol
. 2016 May;
27(8):1565-72.
PMID: 27234640
Background: To examine the relation of carcinoembryonic antigen (CEA) response with tumor response and survival in patients with (K)RAS wild-type metastatic colorectal cancer receiving first-line chemotherapy in the FIRE-3 trial...
10.
Stahler A, Heinemann V, Giessen-Jung C, Crispin A, Schalhorn A, Stintzing S, et al.
Int J Cancer
. 2015 Aug;
138(3):739-46.
PMID: 26284333
Our aim was to investigate the impact of EREG and AREG mRNA expression (by RT-qPCR) in patients with metastatic colorectal cancer (mCRC). In addition, epidermal growth factor receptor (EGFR) expression...